Generic (Common) Name	Brand Name	Company	Year Approved
Protease Inhibitors (PIs)
amprenavir	Agenerase	GlaxoSmithKline	1999; withdrawn 2007
atazanavir	Reyataz	Bristol-Myers Squibb	2003
darunavir (TMC114)	Prezista	Tibotec	2006
fosamprenavir	Lexiva (U.S.); Telzir (Europe)	GlaxoSmithKline	2003
indinavir	Crixivan	Merck	1996
lopinavir/ritonavir	Kaletra	Abbott	2000; Meltrex formulation 2005
nelfinavir	Viracept	Pfizer	1997
ritonavir	Norvir	Abbott	1996
saquinavir	Invirase (hard gel) Fortovase (soft gel)	Roche	1995 1997; withdrawn 2005
tipranavir	Aptivus	Boehringer Ingelheim	2005
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
abacavir	Ziagen	GlaxoSmithKline	1998
didanosine (ddI)	Videx	Bristol-Myers Squibb	1989; Videx EC 2000
emtricitabine (FTC)	Emtriva	Gilead	2003
lamivudine (3TC)	Epivir	GlaxoSmithKline	1995
stavudine (d4T)	Zerit	Bristol-Myers Squibb	1994
tenofovir DF	Viread	Gilead	2002
zalcitabine (ddC)	Hivid	Roche	1992; withdrawn 2005
zidovudine (AZT)	Retrovir	GlaxoSmithKline	1987
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
delavirdine	Rescriptor	Pfizer	1997
efavirenz	Sustiva (U.S.); Stocrin (elsewhere)	Bristol-Myers Squibb	1998
Etravirine	Intelence	Tibotec	2008
nevirapine	Viramune	Boehringer Ingelheim	1996
Other Classes
enfuvirtide (T-20; fusion inhibitor)	Fuzeon	Trimeris	2003
maraviroc (CCR5 antagonist)	Selzentry (U.S.); Celsentri (elsewhere)	Pfizer	2007
raltegravir (integrase inhibitor)	Isentress	Merck	2007
Fixed-Dose Combinations
lamivudine/abacavir (NRTI)	Epzicom (U.S.); Kivexa (Europe)	GlaxoSmithKline	2004
tenofovir/emtricitabine (NRTI)	Truvada	Gilead	2004
tenofovir/emtricitabine/ efavirenz (NRTI/NNRTI)	Atripla	Gilead/Bristol-Myers Squibb	2006
zidovudine/lamivudine (NRTI)	Combivir	GlaxoSmithKline	1997
zidovudine/lamivudine/abacavir (NRTI)	Trizivir	GlaxoSmithKline	2000